EN | 中文
  1. Home
  2. News
  3. FDA Reopens Salmonella Investigation Into Moringa Supplements, Expands Recall

FDA Reopens Salmonella Investigation Into Moringa Supplements, Expands Recall

· By dietarysupplement.ai· Safety
FDA Reopens Salmonella Investigation Into Moringa Supplements, Expands Recall

FDA Reopens Salmonella Investigation Into Moringa Supplements, Expands Recall

Federal health authorities have reopened a multistate outbreak investigation into Salmonella contamination in dietary supplements containing moringa leaf powder. As of May 27, 2026, the FDA and CDC reported 119 total illnesses linked to the contamination, including 22 new cases from four states identified after the investigation's initial closure on March 17, 2026. Multiple dietary supplement brands containing imported moringa leaf powder are now under recall, with products distributed through manufacturers' websites and online retailers including Amazon, eBay, and Walmart.

What happened

The FDA and CDC, in collaboration with state and local health departments, reopened the multistate outbreak investigation on May 27, 2026, following the identification of 22 additional illnesses and new exposure information. The investigation had initially been closed on March 17, 2026, but the emergence of these new cases across four states prompted federal authorities to reinitiate the probe.

Four supplement brands have been identified as part of the recall, with specific lot numbers and expiration dates:

Consumers should locate these products in their homes and discard them immediately along with the containers, even if no illness has occurred.

What the source says

The FDA's outbreak investigation identified two Salmonella serotypes—Salmonella Typhimurium and Salmonella Newport—as the contaminating agents in the imported moringa leaf powder used in the recalled supplements. According to the FDA, Salmonella infection typically manifests symptoms within 12 to 72 hours of exposure, with illness duration ranging from four to seven days. The primary symptoms include diarrhea, fever, and abdominal cramps.

The agency has emphasized that certain populations face heightened risk of severe infection: children under five years old, elderly individuals, and people with compromised immune systems are more likely to experience serious complications requiring hospitalization. The reopened investigation encompasses a total of 119 confirmed illnesses across multiple states, representing a 23% increase from the case count at the time of the March closure.

Beyond the headline

This outbreak reflects a broader vulnerability in the dietary supplement supply chain for imported botanical ingredients. Unlike pharmaceutical drugs, dietary supplements are not required to undergo pre-market safety approval by the FDA; manufacturers bear sole responsibility for ensuring product safety and quality. Moringa leaf powder, marketed as a nutrient-dense supplement ingredient, has grown in popularity over the past decade, driving increased importation from countries with less stringent manufacturing and food safety oversight.

The initial investigation closure in March likely represented a preliminary assessment based on identified case clusters and traced contamination to specific product lots. However, the emergence of 22 new cases within two months of closure—suggesting ongoing exposure or a broader contamination footprint than initially detected—prompted the agency to reopen the investigation and expand its scope. This pattern indicates either that consumers still possess and are consuming recalled products, or that the contamination was more widespread than initially identified.

Industry observers note that moringa powder's popularity combined with importation from regions with variable food safety infrastructure creates particular vulnerability to microbial contamination. The FDA's limited pre-market authority over supplements means the agency can take action only after contamination is identified (through recalls and warning letters), not mandate the rigorous safety testing and facility inspections required for pharmaceutical manufacturers.

What this means for consumers

Consumers who have purchased any of the four recalled moringa supplement brands should immediately locate those products and dispose of them. Do not consume remaining doses, even if no illness has occurred. Contact the selling company (Tnvitamins, Doctor's Pride, Why Not Natural, or Live it Up) to request a refund; most retailers will honor refunds for recalled items given the FDA warning.

If you consumed a recalled moringa supplement and developed diarrhea, fever, or abdominal cramps, contact your healthcare provider immediately and inform them of the supplement consumption and brand name. This information aids diagnosis and ensures appropriate supportive care, particularly hydration management. Most healthy adults recover within four to seven days, but vulnerable populations (children under five, elderly individuals, and those with weakened immune systems) may require hospitalization.

For households with multiple family members or shared kitchen surfaces, carefully clean and sanitize any surfaces or utensils that contacted the recalled products. Use hot soapy water or an FDA-approved disinfectant for food-contact surfaces to reduce cross-contamination risk.

If you wish to continue using green supplement powders, verify that replacement products have been manufactured under third-party testing protocols (look for NSF, USP, or ConsumerLab certification marks on packaging) and confirm the supplier has documented food safety audits. For consumers seeking similar nutritional profiles, whole leafy greens, spirulina from certified suppliers, or supplements from brands with stronger regulatory oversight may present lower contamination risk.

What to watch next

The FDA will continue its investigation into the source of Salmonella contamination in the moringa leaf powder supply chain. Key milestones to monitor include:

Consumers and healthcare providers should continue monitoring the FDA's official outbreak investigation page for updates on case counts, new recalls, or investigation conclusions as new information emerges.

Disclaimer: News coverage on dietarysupplement.ai is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, stopping, or combining supplements. These statements have not been evaluated by the Food and Drug Administration.